GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (FRA:818) » Definitions » Interest Expense

Zylox-Tonbridge Medical Technology Co (FRA:818) Interest Expense : €-0.3 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Zylox-Tonbridge Medical Technology Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Zylox-Tonbridge Medical Technology Co's interest expense for the six months ended in Dec. 2024 was € -0.1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Zylox-Tonbridge Medical Technology Co's Operating Income for the six months ended in Dec. 2024 was € 4.3 Mil. Zylox-Tonbridge Medical Technology Co's Interest Expense for the six months ended in Dec. 2024 was € -0.1 Mil. Zylox-Tonbridge Medical Technology Co's Interest Coverage for the quarter that ended in Dec. 2024 was 33.92. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zylox-Tonbridge Medical Technology Co Interest Expense Historical Data

The historical data trend for Zylox-Tonbridge Medical Technology Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zylox-Tonbridge Medical Technology Co Interest Expense Chart

Zylox-Tonbridge Medical Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial -0.08 -0.04 -0.10 -0.16 -0.29

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.04 -0.05 -0.12 -0.16 -0.13

Zylox-Tonbridge Medical Technology Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zylox-Tonbridge Medical Technology Co  (FRA:818) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Zylox-Tonbridge Medical Technology Co's Interest Expense for the six months ended in Dec. 2024 was €-0.1 Mil. Its Operating Income for the six months ended in Dec. 2024 was €4.3 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was €0.2 Mil.

Zylox-Tonbridge Medical Technology Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2024 )/Interest Expense (Q: Dec. 2024 )
=-1*4.274/-0.126
=33.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Zylox-Tonbridge Medical Technology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (FRA:818) » Definitions » Interest Expense
Comparable Companies
HKSE:02172 HKSE:01302 HKSE:01789 HKSE:01858 HKSE:01763 HKSE:09996 HKSE:02235 HKSE:02291 HKSE:09877 HKSE:06669 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
02190:Hong Kong
Address
270 Shuyun Road, Cangqian Street, Zylox-Tonbridge Industrial Park, Yuhang District, Zhejiang Province, Hangzhou, CHN
Website
https://www.zyloxtb.com
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB).

Zylox-Tonbridge Medical Technology Co Headlines

No Headlines